Dr. Ash Soman has over two decades of experience in pharmaceutical medicine, with a background in clinical development and medical affairs. He holds a medical degree (MBBS) from London, a postgraduate qualification as a Member of the Royal College of Physicians, UK, and an MBA from London.
Dr. Soman has held leadership roles in multinational bio-pharma companies, with expertise in therapeutic areas such as oncology, nuclear medicine, rare diseases, cardiology, pulmonology, diabetology, hepatology, and infectious diseases, including COVID-19 vaccines. He has extensive experience in medical monitoring and patient safety oversight in clinical trials.